{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:05:44Z","timestamp":1793203544719,"version":"4.5.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heparin-induced thrombocytopenia (HIT) is an immune reaction to heparin associated with thrombocytopenia, thrombotic risk, and a high risk of morbidity and mortality. Given the frequent use of heparin and the common occurrence of thrombocytopenia in hospitalized patients, the diagnosis and management of HIT is a recurrent challenge in everyday inpatient care. This article presents practical guidance and tools to support the individual clinician providing evidence-based care to patients with suspected or confirmed HIT. The optimal diagnostic evaluation requires the stepwise use of risk-stratification tools and laboratory assays. Management requires the selection and use of nonheparin anticoagulation in these complex patients with both increased thrombotic risk and possible concurrent increased bleeding risk due to thrombocytopenia. Each step in the diagnostic and management process has important nuances and complexities, many of which vary based on patient characteristics and institutional resources. Given the many challenges of HIT care, truly practical management is best achieved when tools are implemented to support the delivery of consistent, high quality, and cost-effective care across health systems.<\/jats:p>","DOI":"10.1182\/hematology.2024000566","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T10:04:11Z","timestamp":1733479451000},"page":"388-395","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":27,"title":["Practical guide to the diagnosis and management of heparin-induced thrombocytopenia"],"prefix":"10.1182","volume":"2024","author":[{"given":"Jori","family":"May","sequence":"first","affiliation":[{"name":"1 Department of Medicine, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cuker","sequence":"additional","affiliation":[{"name":"2 Department of Medicine and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"5","key":"2024121115504932900_hem2024000566C1","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/S2352-3026(18)30046-2","article-title":"Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study","volume":"5","author":"Dhakal","year":"2018","journal-title":"Lancet Haematol"},{"issue":"4","key":"2024121115504932900_hem2024000566C2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcrc.2005.09.008","article-title":"Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors","volume":"20","author":"Crowther","year":"2005","journal-title":"J Crit Care"},{"issue":"3","key":"2024121115504932900_hem2024000566C3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.V96.3.846","article-title":"Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range","volume":"96","author":"Greinacher","year":"2000","journal-title":"Blood"},{"issue":"22","key":"2024121115504932900_hem2024000566C4","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"suppl 2","key":"2024121115504932900_hem2024000566C5","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"issue":"3","key":"2024121115504932900_hem2024000566C6","doi-asserted-by":"crossref","first-page":"e243786","DOI":"10.1001\/jamanetworkopen.2024.3786","article-title":"Accuracy of diagnosing heparin-induced thrombocytopenia","volume":"7","author":"Larsen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"20","key":"2024121115504932900_hem2024000566C7","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2024121115504932900_hem2024000566C8","doi-asserted-by":"crossref","first-page":"470.e7","DOI":"10.1016\/j.jcrc.2014.02.004","article-title":"Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial","volume":"29","author":"Crowther","year":"2014","journal-title":"J Crit Care"},{"issue":"22","key":"2024121115504932900_hem2024000566C9","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/bloodadvances.2018023077","article-title":"Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia","volume":"2","author":"Pishko","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"2024121115504932900_hem2024000566C10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11239-015-1236-0","article-title":"Consequences of treating false positive heparin-induced thrombocytopenia","volume":"40","author":"Marler","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"11","key":"2024121115504932900_hem2024000566C11","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/jth.14587","article-title":"The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia","volume":"17","author":"Pishko","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2024121115504932900_hem2024000566C12","doi-asserted-by":"crossref","first-page":"102219","DOI":"10.1016\/j.rpth.2023.102219","article-title":"Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review","volume":"7","author":"Cogan","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"2024121115504932900_hem2024000566C13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jth.14359","article-title":"A computerized scoring system to improve assessment of heparin-induced thrombocytopenia risk","volume":"17","author":"Gallo","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2024121115504932900_hem2024000566C14","doi-asserted-by":"crossref","first-page":"101745","DOI":"10.1016\/j.eclinm.2022.101745","article-title":"A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: a prospective, multicenter, observational study","volume":"55","author":"Nilius","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"1","key":"2024121115504932900_hem2024000566C15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/hematology.2021000289","article-title":"Heparin-induced thrombocytopenia and cardiovascular surgery","volume":"2021","author":"Pishko","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"2024121115504932900_hem2024000566C16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.13533","article-title":"The association of anti-platelet factor 4\/heparin antibodies with early and delayed thromboembolism after cardiac surgery","volume":"15","author":"Welsby","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2024121115504932900_hem2024000566C17","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"issue":"suppl 6","key":"2024121115504932900_hem2024000566C18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2016.09.005","article-title":"Acute intraoperative HIT during heart surgery: why so rare?","volume":"146","author":"Warkentin","year":"2016","journal-title":"Thromb Res"},{"issue":"6","key":"2024121115504932900_hem2024000566C19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/jth.13692","article-title":"Diagnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"15","author":"Husseinzadeh","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2024121115504932900_hem2024000566C20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1160\/TH15-06-0523","article-title":"Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. A systematic review and meta-analysis","volume":"115","author":"Sun","year":"2016","journal-title":"Thromb Haemost"},{"issue":"9","key":"2024121115504932900_hem2024000566C21","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.jtha.2023.05.016","article-title":"Limited concordance of heparin\/ platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study","volume":"21","author":"Hammerer-Lercher","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2024121115504932900_hem2024000566C22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.24006","article-title":"The platelet serotonin-release assay","volume":"90","author":"Warkentin","year":"2015","journal-title":"Am J Hematol"},{"issue":"12","key":"2024121115504932900_hem2024000566C23","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1160\/TH07-06-0401","article-title":"Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American specialized coagulation laboratories","volume":"98","author":"Price","year":"2007","journal-title":"Thromb Haemost"},{"issue":"1","key":"2024121115504932900_hem2024000566C24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajh.25660","article-title":"Serotonin-release assay-negative heparin-induced thrombocytopenia","volume":"95","author":"Warkentin","year":"2020","journal-title":"Am J Hematol"},{"issue":"6","key":"2024121115504932900_hem2024000566C25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia","volume":"66","author":"Greinacher","year":"1991","journal-title":"Thromb Haemost"},{"issue":"3","key":"2024121115504932900_hem2024000566C26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.chest.2016.02.641","article-title":"A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia\/thrombosis","volume":"150","author":"Padmanabhan","year":"2016","journal-title":"Chest"},{"issue":"8","key":"2024121115504932900_hem2024000566C27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.2020008195","article-title":"A prospective, blinded study of a PF4-dependent assay for HIT diagnosis","volume":"137","author":"Samuelson Bannow","year":"2021","journal-title":"Blood"},{"issue":"5","key":"2024121115504932900_hem2024000566C28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.14955","article-title":"Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies","volume":"179","author":"Vayne","year":"2017","journal-title":"Br J Haematol"},{"issue":"06","key":"2024121115504932900_hem2024000566C29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0042-1758818","article-title":"Laboratory testing for heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia antibodies: a narrative review","volume":"49","author":"Warkentin","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"2024121115504932900_hem2024000566C30","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"issue":"21","key":"2024121115504932900_hem2024000566C31","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.jacc.2017.09.1099","article-title":"Use of fondaparinux off-label or approved anticoagulants for management of heparin-induced thrombocytopenia","volume":"70","author":"Schindewolf","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2024121115504932900_hem2024000566C32","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1182\/bloodadvances.2022007017","article-title":"Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia","volume":"6","author":"Tuleja","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"2024121115504932900_hem2024000566C33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/08971900221116185","article-title":"The impact of an antithrombotic stewardship program on heparin-induced thrombocytopenia management","volume":"36","author":"Lee","year":"2023","journal-title":"J Pharm Pract"},{"issue":"4","key":"2024121115504932900_hem2024000566C34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s11239-016-1408-6","article-title":"Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program","volume":"42","author":"Ritchie","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"2024121115504932900_hem2024000566C35","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2024121115504932900_hem2024000566C36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2019.1636645","article-title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review","volume":"12","author":"Warkentin","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"16","key":"2024121115504932900_hem2024000566C37","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2015-07-660001","article-title":"Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program","volume":"127","author":"McGowan","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2024121115504932900_hem2024000566C38","doi-asserted-by":"crossref","first-page":"100283","DOI":"10.1016\/j.rpth.2023.100283","article-title":"Heparin-induced thrombocytopenia: an illustrated review","volume":"7","author":"May","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"2024121115504932900_hem2024000566C39","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1111\/j.1538-7836.2010.04059.x","article-title":"The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion","volume":"8","author":"Cuker","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2024121115504932900_hem2024000566C40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/asheducation-2011.1.143","article-title":"How I diagnose and manage HIT","volume":"2011","author":"Warkentin","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"2024121115504932900_hem2024000566C41","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/jth.13758","article-title":"Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia","volume":"15","author":"Raschke","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2024121115504932900_hem2024000566C42","first-page":"106","article-title":"Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach","volume":"40","author":"Cuker","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2024121115504932900_hem2024000566C43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40360-023-00643-4","article-title":"Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol","volume":"24","author":"Ghaziri","year":"2023","journal-title":"BMC Pharmacol Toxicol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/388\/2346640\/388may.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/388\/2346640\/388may.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T15:23:53Z","timestamp":1733930633000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2024\/1\/388\/526210\/Practical-guide-to-the-diagnosis-and-management-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2024000566","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,6]]},"published":{"date-parts":[[2024,12,6]]}}}